The etiology of
anemia in
antineutrophil cytoplasmic antibody (
ANCA)-associated vasculitis (AAV) has not been elucidated. In this cross-sectional study, we tried to investigate the relationship between serum
hepcidin and
anemia in
myeloperoxidase (MPO)-
ANCA-AAV. Data of 64 newly diagnosed AAV patients who did not have kidney dysfunction or
hemorrhage were analyzed. Serum
hepcidin was measured with
enzyme linked
immunosorbent assay. Twenty-three of 64 patients had
anemia. Compared with patients without
anemia, patients with
anemia had higher Birmingham
vasculitis activity score [10 (3, 23) vs. 5 (3, 17), p = 0.020], lower levels of serum
iron (5.83 ± 1.63 vs. 9.76 ± 1.54, p < 0.001) and higher levels of ferrtin [358.00 (59.85, 1314.10) vs. 151.05 (43.00, 645.30), p = 0.006]. All 64 patients had increased levels of serum
hepcidin compared with normal controls, while patients with
anemia had higher serum
hepcidin than patients without
anemia (85.30 ± 16.92 ng/mL vs. 53.48 ± 13.32 ng/mL, p < 0.001). In the multivariable analysis, the level of
hemoglobin correlated with the levels of serum
iron (r = 0.344, p = 0.026) and
hepcidin (r = - 0.353, p = 0.022). Low level of serum
iron was related to high level of serum
hepcidin (r = - 0.472, p = 0.001). Immunosuppressive treatment induced rapid decrease of
hepcidin and increase of serum
iron on the 1st month, while the recovery of
hemoglobin was relatively slow. This study indicated that in MPO-AAV without kidney dysfunction or
hemorrhage, the existence of
anemia is associated with high level of
hepcidin which induces low serum
iron and the abnormality of
iron utilization.